Decision tool for mastectomy choices in new breast cancer
Part of Cancer clinical trials.
This study tests a decision-making tool to help people with newly diagnosed breast cancer make choices about removing the other (opposite) breast as a preventive step. It may help you think through risks and options in a clearer, more structured way.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a new diagnosis of breast cancer in one breast, such as DCIS or stage I–III invasive cancer
- Your cancer is in only one breast (not both)
- You can read, write, or speak English
- You have never had breast cancer before
- You have not already had a preventive mastectomy on both sides
- You do not have a known high-risk genetic mutation (like BRCA1/2) and are not considered very high risk for the other side based on family history
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from people with breast ductal carcinoma in situ (DCIS) to see how a specific lab test (DCISionRT) may help predict who benefits from radiation and/or certain medications. Your results and clinical details are gathered during routine care, not necessarily to change treatment right away.
This study tests a patient-and-caregiver decision guide to help you decide when to start or stop a new cancer drug, join a clinical trial, or continue active surveillance. It aims to make tough choices feel clearer and more supported.
This study tests a decision aid tool that helps women with early-stage breast cancer choose between surgical options. It aims to support you in making a confident, informed decision about your care.
This study is testing a decision tool to help people who are thinking about breast reconstruction surgery after a mastectomy. The tool is designed to help you and your doctor make a more informed choice.
This study tests a digital tool designed to help patients with advanced (stage IV) breast cancer make treatment decisions. The tool may help you understand your options and feel more confident discussing them with your doctor.
This study tests a decision-making tool for Latina breast cancer survivors or those at high risk. It aims to help you make informed choices about breast surgery and reconstruction options.
Hear when a new Anatomic Stage I Breast Cancer AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.